Clinical Trials Directory

Trials / Completed

CompletedNCT03263481

Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim is to evaluate the peak secretory flow rates and bicarbonate concentrations as determined by a 30 minute intraductal secretin stimulation test in patients with a low likelihood of pancreatic pathology and to compare these data to those obtained from our historical patients with suspected chronic pancreatitis. These will be patients in which inadvertent pancreatic cannulation occurs during therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for biliary indications . All study subjects will receive a 5 day follow-up phone call. Enrollment goal is 36 subjects.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntraductal secretin test (IDST)If pancreatic duct entry incidentally occurs during the clinically scheduled ERCP and the pancreatic duct appears normal, an IDST will be performed for study purposes. An IDST consists of the administration of human secretin, after which pancreatic juice is collected intraductally. In this study, the fluid will be collected through continuous aspiration in 5 minute intervals for 30 minutes. Samples will be collected at 5, 10, 15, 20, 25, and 30 minutes after secretin administration (6 collections in total).

Timeline

Start date
2017-09-01
Primary completion
2023-09-01
Completion
2023-09-01
First posted
2017-08-28
Last updated
2023-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03263481. Inclusion in this directory is not an endorsement.